Catálogo de publicaciones - libros
PEACH: Intelligent Interfaces for Museum Visits
Oliviero Stock ; Massimo Zancanaro (eds.)
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
Cultural Heritage; User Interfaces and Human Computer Interaction; Multimedia Information Systems; Artificial Intelligence (incl. Robotics); Computer Appl. in Arts and Humanities; Library Science
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No detectada | 2007 | SpringerLink |
Información
Tipo de recurso:
libros
ISBN impreso
978-3-540-68754-2
ISBN electrónico
978-3-540-68755-9
Editor responsable
Springer Nature
País de edición
Reino Unido
Fecha de publicación
2007
Información sobre derechos de publicación
© Springer-Verlag Berlin Heidelberg 2007
Cobertura temática
Tabla de contenidos
Adaptive Multimedia Guide
C. Rocchi; I. Graziola; D. Goren-Bar; O. Stock; M. Zancanaro
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part I - Intelligent Mobile Guides | Pp. 3-22
Cinematographic Techniques for Automatic Documentary-like Presentations
E. Not; C. Callaway; C. Rocchi; O. Stock; M. Zancanaro
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part I - Intelligent Mobile Guides | Pp. 23-44
Detecting Focus of Attention
R. Brunelli; A. Albertini; C. Andreatta; P. Chippendale; M. Ruocco; O. Stock; F. Tobia; M. Zancanaro
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part I - Intelligent Mobile Guides | Pp. 45-70
Report Generation for Postvisit Summaries in Museum Environments
C. Callaway; E. Not; O. Stock
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part I - Intelligent Mobile Guides | Pp. 71-92
Delivering Services in Active Museums via Group Communication
P. Busetta; P. Bresciani; L. Penserini; S. Rossi; T. Kuflik; A. Albertini; A. Cappelletti
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part II - Infrastructure and User Modelling | Pp. 95-120
User Modelling and Adaptation for a Museum Visitors’ Guide
T. Kuflik; C. Rocchi
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part II - Infrastructure and User Modelling | Pp. 121-144
Integration of Mobile and Stationary Presentation Devices
A. Krüger; M. Kruppa; C. Rocchi
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part III - Stationary Devices | Pp. 147-164
Children in the Museum: an Environment for Collaborative Storytelling
M. Zancanaro; F. Pianesi; O. Stock; P. Venuti; A. Cappelletti; G. Iandolo; M. Prete; F. Rossi
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part III - Stationary Devices | Pp. 165-184
Photorealistic 3D Modelling Applied to Cultural Heritage
F. Voltolini; A. Beraldin; S. El-Hakim; L. Gonzo
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part IV - Virtual Reconstructions and Simulations | Pp. 187-204
Tracking Visitors in a Museum
R. Brunelli; O. Lanz; A. Santuari; F. Tobia
The magnitude of STDs other than HIV in drug users who engage in heterosexual behaviors has not been well assessed in the scientific literature. Similarly, the profile of effective STD risk-reduction interventions for drug users is limited because few interventions have been developed beyond HIV prevention to reduce the risk for the sexual transmission of bacterial and viral STDs in this population. The lack of data on STDs in drug users and on relevant interventions is in marked contrast to the extensive literature on hepatitis B and C(1–4) and HIV (5–8) in drug users.
We aim in this chapter to review and summarize the literature on STDs (excluding HIV) in drug users who engage in heterosexual behaviors and to describe the existing profile of STD-related prevention and control activities specific to drug users. We review three bacterial STDs—syphilis, gonorrhea, and chlamydia—and two viral STDs—hepatitis B and genital herpes. We focus primarily on the scientific studies conducted with heterosexual drug users in the United States, that were published between 1995 and early 2005. Although control of infection with human papilloma virus (HPV) is important for control of cervical cancer, it is worthwhile noting that only two studies were found that mentioned HPV among drug users (9,10), despite the imminent and recent availability of a vaccine for HPV.
Part IV - Virtual Reconstructions and Simulations | Pp. 205-225